Literature DB >> 20524308

Bortezomib in lung transplantation: a promising start.

J Neumann1, S Schio, H Tarrasconi, A Bortolotto, C Costa, T Machuca, S Camargo, L Sanchez, T Michelon, R Canabarro, H Sporleder, S Fernandes, J Camargo, F Perin, J Felicetti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20524308

Source DB:  PubMed          Journal:  Clin Transpl        ISSN: 0890-9016


× No keyword cloud information.
  2 in total

Review 1.  Immunosuppression and allograft rejection following lung transplantation: evidence to date.

Authors:  Gregory I Snell; Glen P Westall; Miranda A Paraskeva
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

2.  Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection.

Authors:  Christine Pham; Brett J Pierce; Duc T Nguyen; Edward A Graviss; Howard J Huang
Journal:  Transplant Direct       Date:  2021-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.